Jazz Pharmaceuticals To Raise $58.5M In Secondary Offering

California-based Jazz Pharmaceuticals JAZZ will raise as much as $58.5 million in a secondary share offering. The company plans to sell 7 million shares to the public at a price of $8.35 a share. The stock is currently trading for $8.44. Barclays Capital BCS is managing the offering, which closes on Friday.